{"id":481226,"title":"Notice: Nirmatrelvir (COVID-19) added to Prescription Drug List (PDL) - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-06","captureTimestamp":"2026-01-06T16:10:22.389000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/amendment-nirmatrelvir.html?wbdisable=true","snippet":"Notice: Nirmatrelvir (COVID-19) added to Prescription Drug List (PDL) January 17, 2022 Our file number: 22-100536-553 The purpose of this Notice of Amendment is to notify about the addition of nirmatrelvir to the Prescription Drug List (PDL) for human and veterinary use. The new…","rawSnapshotUrl":"/api/snapshots/raw/481226","browseUrl":"https://replay.healtharchive.ca/job-6/20260106161022/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/amendment-nirmatrelvir.html?wbdisable=true#ha_snapshot=481226","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}